Assessment of readiness to initiate antiretroviral therapy

Morgenstern, Tanya T.; Grimes, Deanna E.; Grimes, Richard M.

doi:10.1310/t6y6-brcw-ar7a-wva3

Cited by 21 publications

(22 citation statements)

References 5 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Theories of readiness specifically developed for HIV (n = 2) [36,37]; Factors influencing readiness (n = 4) [38][39][40][41]; Tools to systematically assess readiness for HIV treatment (n = 5) [42][43][44][45][46]; Interventions to increase readiness for HIV treatment (n = 4) [39,45,47,48].…”

Section: Resultsmentioning

confidence: 99%

“…It is implied that the emotional responses emerging from the diagnosis [38,40,41], have to be dealt with and overcome in order for HIV patients to consider themselves ready to initiate and adhere to treatment [38]. Dealing with emotional responses from the diagnosis can be seen as a part of the reevaluation of lifestyle described in the first step of the WMT.…”

Section: Discussionmentioning

confidence: 99%

“…Morgenstern et al [38] investigated the factors influencing readiness in 83 HIV-infected patients from a clinic in a metropolitan area. The investigator-developed questionnaire evaluated the timeframe from when the patient found out about the HIV status to when the patient felt ready to start therapy.…”

Section: Factors Negatively Influencing Readiness For Hiv Treatmentmentioning

confidence: 99%

See 2 more Smart Citations

Assessing and achieving readiness to initiate HIV medication

Nordqvist

Södergård

Tully

et al. 2006

Patient Education and Counseling

View full text Add to dashboard Cite

Section: Resultsmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

Section: Factors Negatively Influencing Readiness For Hiv Treatmentmentioning

confidence: 99%

See 1 more Smart Citation

Assessing and achieving readiness to initiate HIV medication

Nordqvist

Södergård

Tully

et al. 2006

Patient Education and Counseling

View full text Add to dashboard Cite

“…readiness for treatment initiation, have, however, been evaluated. Morgenstern et al [40] have investigated the factors influencing readiness for treatment initiation by evaluating the timeframe from when the patient found out about the HIV status to when the patient felt ready to start therapy. In their univariate analysis, some of the emotional responses (anger, hopelessness, denial, anxiety and confusion) following the diagnosis, and their severity, were found to significantly affect readiness for treatment initiation [40].…”

Section: Discussionmentioning

confidence: 99%

The Degree of Readiness among a Population of HIV Infected Patients in Sweden

Södergård¹,

Halvarsson²,

Sönnerborg³

et al. 2016

HIV Curr Res

View full text Add to dashboard Cite

Objective: The objectives were to assess the degree of readiness for HIV infected patients currently on treatment and to evaluate factors potentially influencing readiness.Methods: All HIV-treated patients, who attended a HIV clinic in Sweden, during 7 months, were asked to complete a questionnaire containing Willey´s 2-item readiness assessment and questions about other factors potentially affecting readiness. The Willey´s 2-item readiness assessment categorises patients into either of five stages of change. Patients categorized as in the action or maintenance stage were classified as 'ready to adhere to medicines'. Results:In total 327 patients participated (response rate 87.4%). The proportion categorised as in the action and maintenance stage was 97%. Factors associated with readiness were lower mean CD4 count at start of treatment and lack of resistance. The proportion with viral loads below detection limit was very high (91%). Conclusion:Although the initiation of ART is extremely important, to ensure good treatment results, follow-up and motivation throughout the treatment are also important. Continuous measurement of the patients´ readiness to maintain treatment adherence needs to be further explored.

show abstract

“…In one study of persons in HIV care, only 42% reported entering care immediately after they found that they were HIV positive whereas 12% took more than 1 year to enter care [18]. A study of a cohort representative of the United States' population in care for HIV in the mid-1990s found that, among persons in care within 3 years of their diagnosis, nearly 30% had a delay of at least 3 months, and the median delay was 1 year [19].…”

Section: Step 2-enter Quality Health Care Servicesmentioning

confidence: 99%

The population effectiveness of highly active antiretroviral therapy: Are good drugs good enough?

Giordano

Suarez‐Almazor²,

Grimes³

2005

Curr HIV/AIDS Rep

View full text Add to dashboard Cite

Despite the success of highly active antiretroviral therapy (HAART) at reducing mortality from HIV infection, there is evidence that it is not reaching the all of the population that needs it, even in the developed world. To be maximally effective at the population level, all persons with HIV infection must be diagnosed; those persons with an indication for HAART must enter care, must receive HAART, and then must adhere to appointments and, finally, HAART itself. There is considerable evidence that significant portions of the population infected with HIV have not completed all of these steps of HIV care even in the developed world. Although new medications to treat HIV are certainly needed, significant improvements in viral, immunologic, and clinical outcomes could be achieved from improving timely diagnosis, access to HAART, and adherence to appointments, as well as adherence to HAART.

show abstract

Assessment of readiness to initiate antiretroviral therapy

Abstract: Further research is needed to explain the relationships among emotional responses to HIV diagnosis, readiness to initiate ART, and adherence.

Cited by 21 publications

References 5 publications

Assessing and achieving readiness to initiate HIV medication

Assessing and achieving readiness to initiate HIV medication

The Degree of Readiness among a Population of HIV Infected Patients in Sweden

The population effectiveness of highly active antiretroviral therapy: Are good drugs good enough?

Contact Info

Product

Resources

About